The HEAL Initiative is offering this Career Development Award (K23) to empower early career researchers and clinicians with foundational backgrounds in addiction. This grant is for the purpose of fostering expertise in implementation science, enabling recipients to propose training and research projects that apply these methods to critical areas. Specifically, projects should address at least one of the HHS Overdose Prevention Strategy domains: primary prevention (including appropriate opioid prescribing), OUD treatment, harm reduction, or recovery support services. The overarching goal is to cultivate a new cadre of implementation researchers dedicated to addressing the current overdose crisis, improving the quality of addiction clinical practice, and serving as future experts and mentors in the field.
Opportunity ID: 342297
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-22-207 |
| Funding Opportunity Title: | HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 – Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2022 |
| Last Updated Date: | Jul 14, 2022 |
| Original Closing Date for Applications: | Nov 12, 2025 |
| Current Closing Date for Applications: | Nov 12, 2025 |
| Archive Date: | Dec 18, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses State governments Independent school districts Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Public housing authorities/Indian housing authorities Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This HEAL FOA provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expertise in implementation science. Successful applicants would propose training in implementation science methods, and a research project that would apply these to at least one of the four priority domains of the HHS Overdose Prevention Strategy: primary prevention (including appropriate opioid prescribing), OUD treatment, harm reduction, and/or recovery support services. The overarching goal is to build a cadre of implementation researchers who can contribute to addressing the current overdose crisis, develop research careers that will impact the quality of addiction clinical practice generally, and become the next generation of implementation experts and mentors. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-22-207.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342297 Full Announcement-PAS-22-207 -> PAS-22-207-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00275922 | Sep 12, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278072 | Nov 07, 2022 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289190 | Nov 27, 2024 | Nov 12, 2025 | View |
Package 1
Mandatory forms
342297 RR_SF424_5_0-5.0.pdf
342297 PHS398_CoverPageSupplement_5_0-5.0.pdf
342297 RR_OtherProjectInfo_1_4-1.4.pdf
342297 PerformanceSite_4_0-4.0.pdf
342297 RR_KeyPersonExpanded_4_0-4.0.pdf
342297 RR_Budget_3_0-3.0.pdf
342297 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf
342297 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342297 RR_SubawardBudget30_3_0-3.0.pdf
342297 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
342297 RR_SF424_5_0-5.0.pdf
342297 PHS398_CoverPageSupplement_5_0-5.0.pdf
342297 RR_OtherProjectInfo_1_4-1.4.pdf
342297 PerformanceSite_4_0-4.0.pdf
342297 RR_KeyPersonExpanded_4_0-4.0.pdf
342297 RR_Budget_3_0-3.0.pdf
342297 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf
342297 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342297 RR_SubawardBudget30_3_0-3.0.pdf
342297 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
342297 RR_SF424_5_0-5.0.pdf
342297 PHS398_CoverPageSupplement_5_0-5.0.pdf
342297 RR_OtherProjectInfo_1_4-1.4.pdf
342297 PerformanceSite_4_0-4.0.pdf
342297 RR_KeyPersonExpanded_4_0-4.0.pdf
342297 RR_Budget_3_0-3.0.pdf
342297 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf
342297 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342297 RR_SubawardBudget30_3_0-3.0.pdf
342297 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
